VRNA Verona Pharma PLC ADR

USD 15.22 -0.23 -1.488673
Icon

Verona Pharma PLC ADR (VRNA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 15.22

-0.23 (-1.49)%

USD 1.22B

0.51M

USD 32.86(+115.88%)

USD 18.20 (+19.58%)

Icon

VRNA

Verona Pharma PLC ADR (USD)
COMMON STOCK | NSD
USD 15.22
0.00 0
Take a Tour

Verona Pharma PLC ADR (VRNA) Stock Forecast

Show ratings and price targets of :
USD 32.86
(+115.88%)

Based on the Verona Pharma PLC ADR stock forecast from 4 analysts, the average analyst target price for Verona Pharma PLC ADR is USD 32.86 over the next 12 months. Verona Pharma PLC ADR’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Verona Pharma PLC ADR is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Verona Pharma PLC ADR’s stock price was USD 15.22. Verona Pharma PLC ADR’s stock price has changed by -0.13% over the past week, -5.17% over the past month and -26.54% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...